Neogen Corporation Asset Resilience Ratio
Neogen Corporation asset resilience ratio. Neogen Corporation (NEOG) has an Asset Resilience Ratio of 0.00% as of May 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See NEOG defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Neogen Corporation (1999–2025)
Asset resilience ratio of Neogen Corporation from 1999 to 2025. This chart shows how Neogen Corporation's Asset Resilience Ratio has changed over time. Read NEOG current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Neogen Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Neogen Corporation's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Neogen Corporation maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Neogen Corporation Industry Peers by Asset Resilience Ratio
Compare Neogen Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Neogen Corporation Asset Resilience Ratio by Year (1999–2025)
Neogen Corporation asset resilience ratio by year from 1999 to 2025. The table below shows the annual Asset Resilience Ratio data for Neogen Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-05-31 | 0.00% | $0.00 | $3.44 Billion | -- |
| 2024-05-31 | 0.01% | $325.00K | $4.55 Billion | -1.80pp |
| 2023-05-31 | 1.81% | $82.33 Million | $4.55 Billion | -32.09pp |
| 2022-05-31 | 33.90% | $336.58 Million | $992.93 Million | +0.70pp |
| 2021-05-31 | 33.20% | $305.49 Million | $920.19 Million | -1.60pp |
| 2020-05-31 | 34.80% | $277.40 Million | $797.18 Million | +2.34pp |
| 2019-05-31 | 32.46% | $225.84 Million | $695.74 Million | +11.79pp |
| 2018-05-31 | 20.67% | $127.74 Million | $618.01 Million | +8.17pp |
| 2017-05-31 | 12.50% | $66.07 Million | $528.41 Million | +0.87pp |
| 2016-05-31 | 11.63% | $52.54 Million | $451.71 Million | -0.63pp |
| 2015-05-31 | 12.27% | $48.10 Million | $392.18 Million | +1.89pp |
| 2014-05-31 | 10.37% | $35.82 Million | $345.30 Million | -1.84pp |
| 2013-05-31 | 12.22% | $35.34 Million | $289.25 Million | +4.43pp |
| 2012-05-31 | 7.79% | $19.60 Million | $251.60 Million | -1.42pp |
| 2011-05-31 | 9.21% | $20.24 Million | $219.66 Million | +9.04pp |
| 2006-05-31 | 0.17% | $150.00K | $88.29 Million | -0.38pp |
| 2004-05-31 | 0.55% | $331.00K | $59.98 Million | -15.76pp |
| 2003-05-31 | 16.31% | $7.84 Million | $48.04 Million | +5.43pp |
| 2002-05-31 | 10.88% | $4.34 Million | $39.90 Million | -8.30pp |
| 2001-05-31 | 19.18% | $6.33 Million | $33.02 Million | -9.51pp |
| 2000-05-31 | 28.69% | $8.47 Million | $29.53 Million | -8.09pp |
| 1999-05-31 | 36.78% | $9.60 Million | $26.10 Million | -- |
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage … Read more